JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rubin, B.
Right arrow Articles by Burke, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rubin, B.
Right arrow Articles by Burke, J. C.
Journal of Pharmacology And Experimental Therapeutics, Vol. 107, Issue 2, 219-224, 1953
Copyright © 1953 by American Society for Pharmacology and Experimental Therapeutics


ABSORPTION, DISTRIBUTION AND EXCRETION OF ISONIAZID (NYDRAZID) IN THE DOG

Bernard Rubin 1 and John C. Burke 1

1 The Squibb Institute for Medical Research, New Brunswick, N. J.

After single or repeated oral doses of isoniazid (Nydrazid) in dogs, it was found that:

1. Peak plasma levels of isoniazid generally occurred within thirty minutes and only occasionally as late as two hours.

2. The average 30-minute plasma concentrations were strictly proportional to and, when expressed as microgm./ml., nearly identical with the oral dose in mgm./kgm. of body weight.

3. The average plasma disappearance rate of isoniazid was 19 per cent per hour.

4. Isoniazid was distributed relatively uniformly in blood plasma, spinal fluid and most tissues sampled.

5. There was no chemically detectable cumulation of the drug in body fluids or tissues with chronic doses tolerated for two to eight months.

6. The urinary excretion of isoniazid as apparently unchanged drug reached its peak within 2 to 4 hours and was practically complete within 24 hours.

7. From 44 to 86 per cent of the administered dose could be accounted for as isonicotinic acid plus apparently unchanged isoniazid in the 24 hour urinary output.

The absorption, distribution, and excretion characteristics of isoniazid in the dog appear to be similar to those reported in man.

Submitted on October 7, 1952







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1953 by the American Society for Pharmacology and Experimental Therapeutics.